Skip to content

Point of Care Testing for Advanced Practitioners (Paramedics)

Point of Care Testing (POCT) for Advanced Practitioners (Paramedics) in Urgent and Emergency Care: a Single Site Feasibility Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05054049
Acronym
POCTPara
Enrollment
100
Registered
2021-09-23
Start date
2021-09-30
Completion date
2022-05-31
Last updated
2021-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allied Health Professional, Clinical Decision-Making, Community Urgent & Emergency Care, Point of Care Testing

Keywords

Point of Care Testing, Clinical Decision Making, Paramedic, Community Urgent & Emergency

Brief summary

Point of care testing (POCT) is described as a laboratory test conducted near the patient with a rapid result obtained through a portable analysing device, as opposed to the collection of a blood sample being transferred to a central laboratory for analysis and reporting. Over the past 15 years increasing emphasis has been placed upon the paramedic profession as a possible solution to addressing the increasing demands placed on emergency departments. This is largely viewed through the ability of paramedics to assess patients calling 999 and manage a patient's condition away from the emergency department, with sufficient evidence supporting the role of the paramedic to develop competencies to manage larger volumes of patients. This feasibility study will seek to understand whether paramedics report that the use of POCT devices is useful in safe clinical decision making with patients in the community, and if it is possible to use the Abbott i-STAT device in the urgent and emergency care setting for those patients where management within the community is being considered. Given that there is very little evidence in this subject area, the research should start to inform the potential for future innovations in paramedic and community practice, and build on the body of evidence regarding POCT by paramedics related to community management.

Interventions

DEVICEInterventional Diagnostic Device Arm

Point of care testing venous blood diagnostic device.

OTHERUsual care

Usual care provided to patient without use of point of care testing device

Sponsors

Yorkshire Ambulance Service NHS Trust
Lead SponsorOTHER_GOV
University of Bradford
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
SINGLE (Subject)

Masking description

Patient is randomised to control or intervention arm after consent obtained.

Intervention model description

Single site feasibility study

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

\- Paramedic Participants Inclusion criteria: * HCPC registered paramedics employed as advanced practitioners * From the selected advanced practitioner team (Sheffield) * Able to provide informed consent * Willing to undergo training and to deliver intervention * Willing to undergo training to participate in study measures and processes * Willing to take part in the focus group Patient Participants Inclusion criteria: * Adult patients aged 18 years old and over. * Registered with a GP Surgery in the Sheffield CCG boundary. * In their normal home environment, care home, nursing home or step up intermediate bed service, experiencing an ambulatory sensitive presentation related to falls, frailty, mild to moderate breathlessness, or non-specific general illness and receiving an ambulance service response from participating advanced practitioners (paramedics). * Who do not require immediate life-saving intervention/immediate transfer to ED. * Able to give written consent during the call-out.

Exclusion criteria

\- Paramedic Participants: • Any HCPC registered advanced practitioner (paramedic) who is currently under investigation for fitness to practice. Patient Participants * Patients requiring emergency intervention and immediate transfer to hospital. * Patient does not have mental capacity. * Clinical presentations that should not have any delayed on scene time, meeting the criteria outlined in the YAS policy for the assessment, conveyance and referral of patients, for example detailing the NEWS2 score and other appropriate clinical screening tools that assist in the decision making regarding the decision to convey or refer for community management. * Non-English speaking patients. * End of life care patients. * Patients residing in prison.

Design outcomes

Primary

MeasureTime frameDescription
Self-reported impact of using POCT device1.5 hours focus group at end of studyQualitative focus group data measuring perceived self-reported impact by advanced practitioner (paramedic).

Secondary

MeasureTime frameDescription
72 hour re-contact rateThrough study completion, expected to be 6 monthsProportion of non-conveyed hospital where there was a re-contact to the ambulance service
Type of POCT cartridges used.During the procedureType of POCT cartridges used.
Number of POCT cartridges used.During the procedureNumber of POCT cartridges used.
Number of successful and unsuccessful attempts in using the POCT device.During the procedureNumber of successful and unsuccessful attempts in using the POCT device recorded as a measurement of failure rates
Non-conveyance rateThrough study completion, expected to be 6 monthsProportion of cases not conveyed to hospital
Number of patients who receive POCT.Through study completion, expected to be 6 monthsDescriptive data to understand how many patients were eligible for the POCT device
Patient demographics and presentations where POCT is applied - age, gender, NEWS2 score, clinical condition.Through study completion, expected to be 6 monthsDescriptive data to understand patient characteristics of those patients enrolled into study
Feasibility of patient randomisation processThrough study completion, expected to be 6 monthsDescriptive data to record number of successful and unsuccessful attempts at randomisation of eligible patients
Length of time on scene.immediately after the patient care episode has endedUnderstanding any changes to time spent with patient

Contacts

Primary ContactAndrew Hodge
andrew.hodge1@nhs.net+447798640414
Backup ContactBryan Lightowler
b.lightowler@bradford.ac.uk

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026